Filament is working on a medical-grade version of ayahuasca containing standardized, measurable amounts of its active ingredients. Lightburn hopes that this will open the doors for clinical trials on ayahuasca to be conducted, and they are working on FDA-approved trials for 2023.
This column originally appeared in Cultivated, a cannabis industry newsletter. Subscribe here. You know the…
The DEA has opened a new registration process for state-licensed medical cannabis manufacturers, distributors and…
This November gathering will bring psychedelic education into conversation with music, visual art, comedy, philosophy,…
Ten p.m. on a Glendale balcony, two floors above the theater that just screened the…
We analyzed seven different 2026 rankings to find the true top 10 cannabis strains in…
A land-rooted look at the growers reshaping cannabis through living soil, ecological intelligence and regenerative…